<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>neuropathic patients - Asia Book of Records</title>
	<atom:link href="https://www.asiabookofrecords.com/tag/neuropathic-patients/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.asiabookofrecords.com</link>
	<description>ABR</description>
	<lastBuildDate>Tue, 09 Jun 2026 05:04:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://www.asiabookofrecords.com/wp-content/uploads/2022/07/cropped-Site-Icons-1-32x32.jpg</url>
	<title>neuropathic patients - Asia Book of Records</title>
	<link>https://www.asiabookofrecords.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Maximum Neuropathic Patients Screened Using Vibration Sensory Devices During Awareness Week</title>
		<link>https://www.asiabookofrecords.com/maximum-neuropathic-patients-screened-using-vibration-sensory-devices-during-awareness-week/</link>
		
		<dc:creator><![CDATA[ABR Team]]></dc:creator>
		<pubDate>Tue, 09 Jun 2026 04:58:51 +0000</pubDate>
				<category><![CDATA[Industry & Business]]></category>
		<category><![CDATA[ABR]]></category>
		<category><![CDATA[asia]]></category>
		<category><![CDATA[asia book of records]]></category>
		<category><![CDATA[neuropathic patients]]></category>
		<category><![CDATA[records]]></category>
		<guid isPermaLink="false">https://www.asiabookofrecords.com/?p=24994</guid>

					<description><![CDATA[<p>Medley Pharmaceuticals Ltd., India, set a record for screening the maximum number of neuropathic patients using vibration sensory devices during an awareness week campaign. From May 3 to May 9, 2026, a total of 18,943 neuropathic patients were screened across 552 camps using devices such as Vibrasense, Vibrasense T, HCP Sensitometer, and Biothesiometer. This initiative [...]</p>
<p>The post <a href="https://www.asiabookofrecords.com/maximum-neuropathic-patients-screened-using-vibration-sensory-devices-during-awareness-week/">Maximum Neuropathic Patients Screened Using Vibration Sensory Devices During Awareness Week</a> first appeared on <a href="https://www.asiabookofrecords.com">Asia Book of Records</a>.</p>]]></description>
										<content:encoded><![CDATA[<p>Medley Pharmaceuticals Ltd., India, set a record for screening the maximum number of neuropathic patients using vibration sensory devices during an awareness week campaign. From May 3 to May 9, 2026, a total of 18,943 neuropathic patients were screened across 552 camps using devices such as Vibrasense, Vibrasense T, HCP Sensitometer, and Biothesiometer. This initiative was undertaken to enhance public and clinical awareness about neuropathy and emphasize the importance of routine screening, as confirmed on May 20, 2026.</p><p>The post <a href="https://www.asiabookofrecords.com/maximum-neuropathic-patients-screened-using-vibration-sensory-devices-during-awareness-week/">Maximum Neuropathic Patients Screened Using Vibration Sensory Devices During Awareness Week</a> first appeared on <a href="https://www.asiabookofrecords.com">Asia Book of Records</a>.</p>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
